Skip to ContentSkip to Navigation
Practical matters How to find us D.G. Knapen


89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice

Abstract CT207: A phase 1 open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a Trispecific Humabody® T-cell enhancer, in patients with PSMA+ advanced and/or metastatic solid tumors (POTENTIA)

Molecular imaging to support cancer immunotherapy

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

Reconsider radiation exposure from imaging during immune checkpoint inhibitor trials to reduce risk of secondary cancers in long-term survivors?

Which patients are prone to undergo disproportionate recurrent CT imaging and should we worry?

Pseudomonas aeruginosa meningitis after visiting a swimming pool: A complicated dive

Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever Virus Infections

Read more


Podcast over het coloncarcinoom